Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

Inclusion Criteria: * Healthy male and/or female subjects of non-childbearing potential between the ages of 21 and 55 years, inclusive. * Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight \>50 kg (110 lbs). Exclusion Criteria: * Use of tobacco- or nicotine-containing products in excess of the equivalent of 5 cigarettes per day. * 12-lead ECG demonstrating QTc \>450 msec at screening. * Treatment with an investigational drug within 30 days (or as determined by the local requirement, whichever is longer) or 5 half-lives preceding the first dose of study medication. * History of orthostatic symptoms or orthostatic hypotension at screening. * Pregnant or nursing females; females of childbearing potential.